Evolent Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 02, 2022 at 04:10 pm EDT
Share
Evolent Health, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 319.94 million compared to USD 222.06 million a year ago. Net loss was USD 4.59 million compared to USD 9.11 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.11 a year ago. Basic loss per share was USD 0.05 compared to USD 0.11 a year ago.
For the six months, sales was USD 617 million compared to USD 437.13 million a year ago. Net loss was USD 9.94 million compared to USD 18.91 million a year ago. Basic loss per share from continuing operations was USD 0.11 compared to USD 0.24 a year ago. Basic loss per share was USD 0.11 compared to USD 0.22 a year ago.
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
EVOLENT HEALTH, INC. 
